{"database": "openregs", "table": "documents", "rows": [["FDA-2014-D-1814-0061", "FDA", "FDA-2014-D-1814", "Reference 30 Clostridium perfringens in apheresis platelets an unusual contaminant underscores the importance of clinical vigilance for septic transfusion reactions re Bacterial Detection Testing by Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion; Draft Guidance for Industry; Availability", "Supporting & Related Material", "Background Material", "2016-03-16T04:00:00Z", 2016, 3, null, null, "2016-03-16T17:41:54Z", null, 0, 0, "0900006481ec38da"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2014-D-1814-0061"], "units": {}, "query_ms": 50.70447502657771, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}